Join Clarivate and DIA for an evening of networking and baseball

Register your interest for either Tuesday June 27 or Wednesday June 28

Fancy an evening of networking and baseball with Clarivate?

The Boston Red Sox will be in town for two evening games during DIA 2023, and Fenway has blocked a dedicated seating area for DIA Attendees for both games! Both games are at 7:10PM EDT and against the Miami Marlins.
Clarivate has a number of seats for valued clients such as yourself, if your interested in joining us on either Tuesday June 27 or Wednesday June 28, then register your interest via the form on this page
Not yet registered for DIA 2023?
Then use our code for a discount
As a valued customer we would like to extend a registration discount, you can get $100 off a full registration pass, or, if you are looking for an exhibit hall only pass you can reduce the cost to $200. 
The codes to use are:
  • $100 off full registration pass: VIP23160
  • $200 exhibit hall only pass: HALL23160
Click here to register for DIA 2023
Click to enlarge

Provide your details to register your interest




HIDDEN FIELDS BELOW

“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces better outcomes.”

Tomomi Asano, Manager of the Public Service Group at International Christian University Library

“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces better outcomes.”

Tomomi Asano, Manager of the Public Service Group at International Christian University Library

“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces better outcomes.”

Tomomi Asano, Manager of the Public Service Group at International Christian University Library

With over 45,000 customers in more than 190 countries, Clarivate supports pharmacovigilance, drug safety and regulatory professionals from the world’s leading companies. 

Our aim is to help our customers build a proactive strategy in their journey toward Submission Excellence.  
 
We understand the need to optimize the submission strategy process. With a success rate of just about 12% of drugs entering clinical development being approved, a proactive regulatory strategy gains further importance.   
 
Clarivate Regulatory solutions help biopharma:  
  • Achieve Regulatory Submission Excellence  
  • Mitigate Risk & Ensure Compliance  
  • Secure Regulatory Success

Research and development
 

Optimize drug discovery and strategically translate your drug from the lab to the clinic by equipping your teams with the data they need to make confident research and development decisions. Overcome the challenges of finding, integrating and analyzing key information and free up your teams to focus on accelerating drug R&D and getting patients’ lifesaving therapies quicker.

Click here to find out more

Pharmacovigilance and Drug Safety

Enable your pharmacovigilance experts to keep focus on what matters most – patient safety – by using tools and a process that simplifies the repetitive and tedious literature review. Transparently measure the productivity, quality and timeliness of the work performed by your multiple teams. Be confident that your operation is under control, inspection ready, and compliant.


Click here to find out more

Regulatory and compliance
 

Enable all regulatory and compliance teams to easily track changing legislation and monitor drug safety risks with high-quality, comprehensive regulatory, pharmacovigilance and HTA intelligence. Overcome the challenges of identifying and monitoring the latest guidelines, adverse events, and HTA outcomes and empower your teams to focus on setting your therapies up for regulatory and HTA success.

Click here to find out more

Modernize regulatory and quality assurance workflows through advanced technology

Quality and regulatory functions are challenged by the expanding nature and variety of products (e.g., biologics, cell and gene therapies, companion diagnostics, delivery devices, digital health) as well as the depth and breadth of regulatory changes. Managing this diversity and change can be a strain on internal resources.

View our new eBook to access detailed insights as it takes a closer look at how AI and automation have the potential to streamline the maintenance of the regulatory lifecycle, particularly SOP monitoring, and updates.
Download the eBook